e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Recent developments in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2011 Abstract: The role of lipoxin A4 in the chronic obstructive pulmonary disease
L. Balode, G. Strazda, N. Jurka, U. Kopeika, A. Kislina, M. Beinare, M. Bukovskis, I. Taivans (Riga, Latvia)
Source:
Annual Congress 2011 - Recent developments in COPD
Session:
Recent developments in COPD
Session type:
Poster Discussion
Number:
414
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Balode, G. Strazda, N. Jurka, U. Kopeika, A. Kislina, M. Beinare, M. Bukovskis, I. Taivans (Riga, Latvia). LSC 2011 Abstract: The role of lipoxin A4 in the chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 414
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Chronic obstructive pulmonary disease is characterized with suppressed lipoxin A4 and increased lipoxin receptor expression in lungs
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012
Survivin in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Chronic obstructive pulmonary disease (COPD) – patient‘s perspective
Source: Eur Respir J 2007; 30: Suppl. 51, 168s
Year: 2007
Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Chronic obstructive pulmonary disease: the patient perspective
Source: Eur Respir J 2001; 18: Suppl. 33, 401s
Year: 2001
Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002
Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 23: 629-636
Year: 2004
LSC Abstract – microRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009
Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study
Source: Eur Respir J 2010; 36: 89-95
Year: 2010
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 488-496
Year: 2002
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Role of antibiotics in exacerbations of chronic obstructive pulmonary disease: a Cochrane review
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept